Suppr超能文献

促红细胞生成素可保护大鼠肠道免受缺血/再灌注损伤。

Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats.

作者信息

Guneli Ensari, Cavdar Zahide, Islekel Huray, Sarioglu Sulen, Erbayraktar Serhat, Kiray Muge, Sokmen Selman, Yilmaz Osman, Gokmen Necati

机构信息

Department of Laboratory Animal Sciences, Health Sciences Institute, Dokuz Eylul, University, Izmir, Turkey.

出版信息

Mol Med. 2007 Sep-Oct;13(9-10):509-17. doi: 10.2119/2007-00032.Guneli.

Abstract

Previous studies have shown that erythropoietin (EPO) has protective effects against ischemia/reperfusion (I/R) injury in several tissues. The aim of this study was to determine whether EPO could prevent intestinal tissue injury induced by I/R. Wistar rats were subjected to intestinal ischemia (30 min) and reperfusion (60 min). A single dose of EPO (5000 U/kg) was administered intraperitoneally at two different time points: either at five minutes before the onset of ischemia or at the onset of reperfusion. At the end of the reperfusion period, jejunum was removed for examinations. Myeloperoxidase (MPO), malondialdehyde (MDA), and antioxidant defense system were assessed by biochemical analyses. Histological evaluation was performed according to the Chiu scoring method. Endothelial nitric oxide synthase (eNOS) was demonstrated by immunohistochemistry. Apoptotic cells were determined by TUNEL staining. Compared with the sham, I/R caused intestinal tissue injury (Chiu score, 3+/-0.36 vs 0.4+/-0.24, P<0.01) and was accompanied by increases in MDA levels (0.747+/-0.076 vs 0.492+/-0.033, P<0.05), MPO activity (10.51+/-1.87 vs 4.3+/-0.45, P<0.05), intensity of eNOS immunolabelling (3+/-0.4 vs 1.3+/-0.33, P<0.05), the number of TUNEL-positive cells (20.4+/-2.6 vs 4.6+/-1.2, P<0.001), and a decrease in catalase activity (16.83+/-2.6 vs 43.15+/-4.7, P<0.01). Compared with the vehicle-treated I/R, EPO improved tissue injury; decreased the intensity of eNOS immunolabelling (1.6+/-0.24 vs 3+/-0.4, P<0.05), the number of TUNEL-positive cells (9.2+/-2.7 vs 20.4+/-2.6, P<0.01), and the high histological scores (1+/-0.51 vs 3+/-0.36, P<0.01), and increased catalase activity (42.85+/-6 vs 16.83+/-2.6, P<0.01) when given before ischemia, while it was found to have decreased the levels of MDA (0.483+/-0.025 vs 0.747+/-0.076, P<0.05) and MPO activity (3.86+/-0.76 vs 10.51+/-1.87, P<0.05), intensity of eNOS immunolabelling (1.4+/-0.24 vs 3+/-0.4, P<0.01), the number of TUNEL-positive cells (9.1+/-3 vs 20.4+/-2.6, P<0.01), and the number of high histological scores (1.16+/-0.4 vs 3+/-0.36, P<0.05) when given at the onset of reperfusion. These results demonstrate that EPO protects against intestinal I/R injury in rats by reducing oxidative stress and apoptosis. We attributed this beneficial effect to the antioxidative properties of EPO.

摘要

以往研究表明,促红细胞生成素(EPO)对多种组织的缺血/再灌注(I/R)损伤具有保护作用。本研究旨在确定EPO是否能预防I/R诱导的肠道组织损伤。将Wistar大鼠进行肠道缺血(30分钟)和再灌注(60分钟)。在两个不同时间点腹腔注射单剂量EPO(5000 U/kg):要么在缺血开始前5分钟,要么在再灌注开始时。在再灌注期结束时,取出空肠进行检查。通过生化分析评估髓过氧化物酶(MPO)、丙二醛(MDA)和抗氧化防御系统。根据Chiu评分法进行组织学评估。通过免疫组织化学检测内皮型一氧化氮合酶(eNOS)。通过TUNEL染色确定凋亡细胞。与假手术组相比,I/R导致肠道组织损伤(Chiu评分,3±0.36对0.4±0.24,P<0.01),并伴有MDA水平升高(0.747±0.076对0.492±0.033,P<0.05)、MPO活性升高(10.51±1.87对4.3±0.45,P<0.05)、eNOS免疫标记强度升高(3±0.4对1.3±0.33,P<0.05)、TUNEL阳性细胞数量增加(20.4±2.6对4.6±1.2,P<0.001)以及过氧化氢酶活性降低(16.83±2.6对43.15±4.7,P<0.01)。与给予赋形剂的I/R组相比,EPO改善了组织损伤;在缺血前给予时,降低了eNOS免疫标记强度(1.6±0.24对3±0.4,P<0.05)、TUNEL阳性细胞数量(9.2±2.7对20.4±2.6,P<0.01)以及高组织学评分(1±0.51对3±0.36,P<0.01),并增加了过氧化氢酶活性(42.85±6对16.83±2.6,P<0.01);而在再灌注开始时给予时,发现其降低了MDA水平(0.483±0.025对0.747±0.076,P<0.05)、MPO活性(3.86±0.76对10.51±1.87,P<0.05)、eNOS免疫标记强度(1.4±0.24对3±0.4,P<0.01)、TUNEL阳性细胞数量(9.1±3对20.4±2.6,P<0.01)以及高组织学评分数量(1.16±0.4对3±0.36,P<0.05)。这些结果表明,EPO通过降低氧化应激和细胞凋亡来保护大鼠免受肠道I/R损伤。我们将这种有益作用归因于EPO的抗氧化特性。

相似文献

1
Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats.
Mol Med. 2007 Sep-Oct;13(9-10):509-17. doi: 10.2119/2007-00032.Guneli.
2
Protective effects of thymoquinone and melatonin on intestinal ischemia-reperfusion injury.
Saudi J Gastroenterol. 2015 Sep-Oct;21(5):284-9. doi: 10.4103/1319-3767.166203.
4
Protective effect of sildenafil on liver injury induced by intestinal ischemia/reperfusion.
J Pediatr Surg. 2013 Aug;48(8):1707-15. doi: 10.1016/j.jpedsurg.2012.12.054.
5
Protective effect of erythropoietin on torsion/detorsion injury in rat model.
J Pediatr Surg. 2009 Oct;44(10):1988-94. doi: 10.1016/j.jpedsurg.2009.02.071.
6
The Effect of Erythropoietin in Preventing Ischemia-Reperfusion Injury in Ovarian Tissue Transplantation.
Reprod Sci. 2018 Mar;25(3):406-413. doi: 10.1177/1933719117715127. Epub 2017 Jun 28.
8
Picroside II attenuates ischemia/reperfusion testicular injury by alleviating oxidative stress and apoptosis through reducing nitric oxide synthesis.
Acta Cir Bras. 2019 Dec 20;34(11):e201901102. doi: 10.1590/s0102-865020190110000002. eCollection 2019.

引用本文的文献

1
The effect of haemoglobin and blood transfusion on preterm infant gut perfusion and injury.
Front Pediatr. 2024 Nov 22;12:1440537. doi: 10.3389/fped.2024.1440537. eCollection 2024.
2
Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review.
Cell Death Discov. 2024 Mar 4;10(1):112. doi: 10.1038/s41420-024-01891-x.
3
Enteric fungi protect against intestinal ischemia-reperfusion injury via inhibiting the SAA1-GSDMD pathway.
J Adv Res. 2024 Jul;61:223-237. doi: 10.1016/j.jare.2023.09.008. Epub 2023 Sep 16.
4
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases.
Front Oncol. 2022 Mar 10;12:860508. doi: 10.3389/fonc.2022.860508. eCollection 2022.
5
Protective effect of parecoxib sodium against ischemia reperfusion‑induced intestinal injury.
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12416. Epub 2021 Sep 9.
6
Mesna ameliorates acute lung injury induced by intestinal ischemia-reperfusion in rats.
Sci Rep. 2021 Jun 25;11(1):13356. doi: 10.1038/s41598-021-92653-7.
9
Influence of Growth Factors on the Development of Necrotizing Enterocolitis.
Clin Perinatol. 2019 Mar;46(1):51-64. doi: 10.1016/j.clp.2018.10.005. Epub 2018 Dec 20.

本文引用的文献

1
Myeloperoxidase: a key regulator of neutrophil oxidant production.
Redox Rep. 1997 Feb;3(1):3-15. doi: 10.1080/13510002.1997.11747085.
2
Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock.
Br J Pharmacol. 2007 Jun;151(3):377-83. doi: 10.1038/sj.bjp.0707233. Epub 2007 Apr 23.
3
Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice.
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H274-83. doi: 10.1152/ajpheart.01031.2006. Epub 2007 Mar 2.
4
Carbamylated erythropoietin reduces radiosurgically-induced brain injury.
Mol Med. 2006 Apr-Jun;12(4-6):74-80. doi: 10.2119/2006-00042.Erbayraktar.
5
Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
Kidney Int. 2006 Jul;70(2):246-50. doi: 10.1038/sj.ki.5001546. Epub 2006 May 31.
6
Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.
Eur J Cardiothorac Surg. 2006 Jun;29(6):902-7. doi: 10.1016/j.ejcts.2006.02.036. Epub 2006 May 3.
7
Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
Life Sci. 2006 Apr 4;78(19):2255-64. doi: 10.1016/j.lfs.2005.09.053. Epub 2005 Dec 5.
8
Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain.
Brain Res Dev Brain Res. 2005 Dec 7;160(2):146-56. doi: 10.1016/j.devbrainres.2005.08.006. Epub 2005 Oct 19.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验